A Phase II Study of Rituxan and IL-2 [interleukin 2] in Patients With Low Grade or Follicular B-Cell Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary) ; Rituximab
- Indications Follicular lymphoma; Mantle-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 16 Oct 2013 Biomarkers information updated
- 11 Sep 2005 New trial record.